Closing the door on KRAS-mutant lung cancer

被引：5
|
作者：
Cully, Megan
机构：
来源：
NATURE REVIEWS DRUG DISCOVERY | 2016年 / 15卷 / 11期
关键词：
D O I：
10.1038/nrd.2016.216
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：747 / 747
页数：1
相关论文
共 50 条
  • [41] An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy Combinations
    Boumelha, Jesse
    Trecesson, Sophie de Carne
    Law, Emily K.
    Romero-Clavijo, Pablo
    Coelho, Matthew A.
    Ng, Kevin W.
    Mugarza, Edurne
    Moore, Christopher
    Rana, Sareena
    Caswell, Deborah R.
    Murillo, Miguel
    Hancock, David C.
    Argyris, Prokopios P.
    Brown, William L.
    Durfee, Cameron
    Larson, Lindsay K.
    Vogel, Rachel, I
    Suarez-Bonnet, Alejandro
    Priestnall, Simon L.
    East, Philip
    Ross, Sarah J.
    Kassiotis, George
    Molina-Arcas, Miriam
    Swanton, Charles
    Harris, Reuben
    Downward, Julian
    CANCER RESEARCH, 2022, 82 (19) : 3435 - 3448
  • [42] Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer
    Giorgia Maroni
    Mahmoud A. Bassal
    Indira Krishnan
    Chee Wai Fhu
    Virginia Savova
    Rapolas Zilionis
    Valerie A. Maymi
    Nicole Pandell
    Eva Csizmadia
    Junyan Zhang
    Barbara Storti
    Julio Castaño
    Riccardo Panella
    Jia Li
    Corinne E. Gustafson
    Sam Fox
    Rachel D. Levy
    Claire V. Meyerovitz
    Peter J. Tramontozzi
    Kimberly Vermilya
    Assunta De Rienzo
    Stefania Crucitta
    Daniela S. Bassères
    Marla Weetall
    Art Branstrom
    Alessandra Giorgetti
    Raffaele Ciampi
    Marzia Del Re
    Romano Danesi
    Ranieri Bizzarri
    Henry Yang
    Olivier Kocher
    Allon M. Klein
    Robert S. Welner
    Raphael Bueno
    Maria Cristina Magli
    John G. Clohessy
    Azhar Ali
    Daniel G. Tenen
    Elena Levantini
    Communications Biology, 4
  • [43] Management of KRAS-Mutant Non-Small Cell Lung Cancer in the Era of Precision Medicine
    Aredo, Jacqueline V.
    Padda, Sukhmani K.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2018, 19 (08)
  • [44] Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer
    Maroni, Giorgia
    Bassal, Mahmoud A.
    Krishnan, Indira
    Fhu, Chee Wai
    Savova, Virginia
    Zilionis, Rapolas
    Maymi, Valerie A.
    Pandell, Nicole
    Csizmadia, Eva
    Zhang, Junyan
    Storti, Barbara
    Castano, Julio
    Panella, Riccardo
    Li, Jia
    Gustafson, Corinne E.
    Fox, Sam
    Levy, Rachel D.
    Meyerovitz, Claire, V
    Tramontozzi, Peter J.
    Vermilya, Kimberly
    De Rienzo, Assunta
    Crucitta, Stefania
    Basseres, Daniela S.
    Weetall, Marla
    Branstrom, Art
    Giorgetti, Alessandra
    Ciampi, Raffaele
    Del Re, Marzia
    Danesi, Romano
    Bizzarri, Ranieri
    Yang, Henry
    Kocher, Olivier
    Klein, Allon M.
    Welner, Robert S.
    Bueno, Raphael
    Magli, Maria Cristina
    Clohessy, John G.
    Ali, Azhar
    Tenen, Daniel G.
    Levantini, Elena
    COMMUNICATIONS BIOLOGY, 2021, 4 (01)
  • [45] Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer
    Caterina Bartolacci
    Cristina Andreani
    Gonçalo Vale
    Stefano Berto
    Margherita Melegari
    Anna Colleen Crouch
    Dodge L. Baluya
    George Kemble
    Kurt Hodges
    Jacqueline Starrett
    Katerina Politi
    Sandra L. Starnes
    Daniele Lorenzini
    Maria Gabriela Raso
    Luisa M. Solis Soto
    Carmen Behrens
    Humam Kadara
    Boning Gao
    Ignacio I. Wistuba
    John D. Minna
    Jeffrey G. McDonald
    Pier Paolo Scaglioni
    Nature Communications, 13
  • [46] XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer
    Kim, Jimi
    McMillan, Elizabeth
    Kim, Hyun Seok
    Venkateswaran, Niranjan
    Makkar, Gurbani
    Rodriguez-Canales, Jaime
    Villalobos, Pamela
    Neggers, Jasper Edgar
    Mendiratta, Saurabh
    Wei, Shuguang
    Landesman, Yosef
    Senapedis, William
    Baloglu, Erkan
    Chow, Chi-Wan B.
    Frink, Robin E.
    Gao, Boning
    Roth, Michael
    Minna, John D.
    Daelemans, Dirk
    Wistuba, Ignacio I.
    Posner, Bruce A.
    Scaglioni, Pier Paolo
    White, Michael A.
    NATURE, 2016, 538 (7623) : 114 - +
  • [47] Prognostic values, ceRNA network, and immune regulation function of SDPR in KRAS-mutant lung cancer
    Luo, Xiaoqing
    Peng, Shunli
    Ding, Sijie
    Zeng, Qin
    Wang, Rong
    Ma, Yueyun
    Chen, ShiYu
    Wang, Yanxia
    Wang, Wei
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [48] XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer
    Jimi Kim
    Elizabeth McMillan
    Hyun Seok Kim
    Niranjan Venkateswaran
    Gurbani Makkar
    Jaime Rodriguez-Canales
    Pamela Villalobos
    Jasper Edgar Neggers
    Saurabh Mendiratta
    Shuguang Wei
    Yosef Landesman
    William Senapedis
    Erkan Baloglu
    Chi-Wan B. Chow
    Robin E. Frink
    Boning Gao
    Michael Roth
    John D. Minna
    Dirk Daelemans
    Ignacio I. Wistuba
    Bruce A. Posner
    Pier Paolo Scaglioni
    Michael A. White
    Nature, 2016, 538 : 114 - 117
  • [49] Dissecting tumor cell heterogeneity to identify therapeutic vulnerabilities in Kras-mutant lung cancer.
    Padhye, Aparna
    Rodriguez, B. Leticia
    Fradette, Jared J.
    Ungewiss, Christin
    Gibbons, Don L.
    MOLECULAR CANCER RESEARCH, 2020, 18 (05) : 55 - 55
  • [50] Divide and conquer: towards isoform-specific diagnosis and therapy of KRAS-mutant lung cancer
    Allemann, Anna T.
    Gautschi, Oliver
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (06) : 1328 - 1331
12345